GSK Plc’s shingles vaccine was linked to a lower risk of cardiovascular disease in a major study, potentially boosting the chances of wider usage for the drugmaker’s top-selling product.
Ashleigh Furlong is a health care reporter at Bloomberg. She specializes in public health, pharmaceutical regulation, and consumer health, covering a wide range of topics including drugs and medication, immunology, and oncology. Ashleigh's work has been featured in prominent outlets such as Yahoo Finance, Scientific American, and TIME.
